Skip to main content
Retour
RAFLF logo

Raffles Medical Group Ltd

Qualité des données : 100%
Suracheté
RAFLF
OTC Healthcare Medical - Care Facilities
0,80 €
0,00 € (0,00%)
Cap. Boursière : 1,47B
Fourchette du Jour
0,72 € 0,80 €
Fourchette 52 Semaines
0,60 € 0,83 €
Volume
3 000
Moyenne 50J / 200J
0,75 € / 0,76 €
Clôture Précédente
0,80 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (633 pairs)

Métrique Action Médiane du Secteur
P/E 20,9 0,2
P/B 1,4 2,8
ROE % 6,7 3,7
Net Margin % 9,2 3,9
Rev Growth 5Y % 1,4 9,7
D/E 0,1 0,2

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2028 0,04 €
0,04 € – 0,04 €
868,08M 1
FY2027 0,03 €
0,03 € – 0,03 €
830,39M 1
FY2026 0,03 €
0,03 € – 0,03 €
794,44M 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-23 N/A 0,02 €
2025-07-28 N/A 0,01 €
2025-02-23 N/A 0,01 €
2024-07-29 N/A 0,01 €
2024-04-26 N/A 0,01 €
2024-02-26 N/A 0,01 €
2023-12-30 N/A 0,01 €
2023-06-29 N/A 0,02 €

Dividend History

7 yr streak

Yield

0,03%

Payout Ratio

0,66%

Growth (3Y)

-1,34%

Growth (5Y)

1,29%

Ex-Date Payment Date Amount Yield
May 14, 2026 May 22, 2026 0,02 € 2,92%
May 15, 2025 May 23, 2025 0,02 € 3,22%
May 14, 2024 May 23, 2024 0,02 € 2,40%
May 15, 2023 May 25, 2023 0,03 € 2,63%
May 09, 2022 May 19, 2022 0,02 € 1,97%
May 10, 2021 May 20, 2021 0,02 € 2,18%
Sep 28, 2020 Oct 07, 2020 0,00 € 2,88%
Aug 03, 2020 Sep 16, 2020 0,01 € 2,11%
Aug 19, 2019 Aug 30, 2019 0,00 € 2,46%
May 13, 2019 Jun 27, 2019 0,01 € 3,02%
Aug 27, 2018 Sep 06, 2018 0,00 € 2,65%
May 14, 2018 Jun 29, 2018 0,01 € 1,87%
Aug 21, 2017 Aug 31, 2017 0,00 € 1,45%
May 08, 2017 Jun 29, 2017 0,01 € 1,38%
Aug 22, 2016 Aug 31, 2016 0,00 € 0,74%
May 09, 2016 Jun 28, 2016 0,03 € 0,53%
Aug 17, 2015 Aug 31, 2015 0,01 € 1,21%
May 04, 2015 Jun 18, 2015 0,03 € 1,40%
Aug 18, 2014 Aug 29, 2014 0,01 € 1,38%
May 05, 2014 Jun 26, 2014 0,03 € 1,53%

Points Clés

Revenue grew 1,38% annually over 5 years — modest growth
Debt/Equity of 0,11 — conservative balance sheet
Generating 98,04M in free cash flow
Cash machine — converts 139,03% of earnings into free cash flow
Capital efficient — spends only 1,03% of revenue on capex

Croissance

Revenue Growth (5Y)
1,38%
Revenue (1Y)1,75%
Earnings (1Y)13,29%
FCF Growth (3Y)-23,79%

Qualité

Return on Equity
6,69%
ROIC5,84%
Net Margin9,22%
Op. Margin11,93%

Sécurité

Debt / Equity
0,11
Current Ratio1,31
Interest Coverage22,30

Valorisation

P/E Ratio
20,88
Forward P/E25,97
P/B Ratio1,39
EV/EBITDA13,98
Dividend Yield0,03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1,75% Revenue Growth (3Y) 3,93%
Earnings Growth (1Y) 13,29% Earnings Growth (3Y) -11,56%
Revenue Growth (5Y) 1,38% Earnings Growth (5Y) -4,33%
Profitability
Revenue (TTM) 764,73M Net Income (TTM) 70,52M
ROE 6,69% ROA 4,94%
Gross Margin 17,87% Operating Margin 11,93%
Net Margin 9,22% Free Cash Flow (TTM) 98,04M
ROIC 5,84% FCF Growth (3Y) -23,79%
Safety
Debt / Equity 0,11 Current Ratio 1,31
Interest Coverage 22,30
Dividends
Dividend Yield 0,03% Payout Ratio 0,66%
Dividend Growth (3Y) -1,34% Dividend Growth (5Y) 1,29%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 20,88 Forward P/E 25,97
P/B Ratio 1,39 P/S Ratio 1,93
PEG Ratio 1,77 Forward PEG N/A
EV/EBITDA 13,98 Fwd EV/EBITDA 7,62
Forward P/S 1,85 Fwd Earnings Yield 3,85%
FCF Yield 6,66%
Market Cap 1,47B Enterprise Value 1,28B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 764,73M 751,56M 708,03M 822,92M 723,79M
Net Income 70,52M 62,24M 90,15M 143,21M 84,17M
EPS (Diluted) 0,04 0,03 0,05 0,08 0,04
Gross Profit 136,63M 486,14M 315,94M 639,98M 580,52M
Operating Income 91,27M 82,49M 115,76M 195,85M 121,31M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,43B 1,53B 1,53B 1,50B 1,55B
Total Liabilities 373,70M 465,82M 484,38M 467,30M 568,67M
Shareholders' Equity 1,06B 1,05B 1,03B 1,02B 960,79M
Total Debt 114,76M 88,17M 124,70M 96,14M 198,13M
Cash & Equivalents 310,56M 343,67M 343,60M 253,13M 264,99M
Current Assets 435,48M 516,32M 484,70M 494,35M 439,10M
Current Liabilities 333,33M 381,94M 379,38M 362,99M 416,61M